Expansion of CD4+ Foxp3+ Treg cells in the peripheral blood has been reported in patients with autoimmune diseases after intravenous administration of high-dose (1~2 g/Kg of body weight) heterologous IVIg (60, 65, 93). This evidence concerns the gene FOXP3 and autoimmune disease.